2024 Rome, Italy
Meeting information
Abstracts
Programme Item
Presenter
Abstract Category
Search Abstract
II-69 Meng Zhaoling
Exposure/Response modeling for sarilumab dose regimens benefit/risk assessment
Wednesday 15:10-16:30
